IAOTP names Jahanara Miotto Top Global Leader in R&D

By AI, Created 5:56 PM UTC, May 28, 2026, /AGP/ – The International Association of Top Professionals will honor Jahanara Miotto at its annual gala in New York City this December. The award recognizes her decades in pharmaceutical research and development and her leadership at Metrendalytics.

Why it matters: - IAOTP’s recognition puts a national spotlight on Miotto’s work in pharmaceutical research and development. - The honor also lifts visibility for Metrendalytics, a company focused on turning life-sciences data into faster operational insight.

What happened: - The International Association of Top Professionals selected Jahanara Miotto as Top Global Leader of the Year in Research and Development 2026. - IAOTP will honor Miotto at its Annual Awards Gala this December at the Plaza Hotel in New York City. - Miotto is the Founder and President of Metrendalytics L.L.C., a role she has held since 2014.

The details: - Miotto has more than 30 years of professional experience in pharmaceutical research and development. - Metrendalytics builds customized business intelligence and informatics solutions for global life-sciences organizations. - The company’s platforms are designed to combine data from multiple systems into a centralized database and share that information with large groups of stakeholders in near real time. - Metrendalytics says its tools support operational performance management, risk mitigation and better decision-making. - The company says its platform was designed by scientists for scientists and has earned recognition and multiple awards. - Before founding Metrendalytics, Miotto held roles at Eisai Medical Research, Nexgenix Pharmaceutical, Par Pharmaceutical, Purdue Pharma and Novartis. - Her experience spans business management, operations and project management, clinical development, business analytics, planning and finance, biotechnology, clinical trials, biopharmaceuticals, CRO management, bioanalysis, clinical operations, drug development and pharmaceutical R&D. - Miotto earned a bachelor’s degree in chemistry and mathematics from Queens College. - She also holds a master’s degree in analytical chemistry from CUNY City College. - Miotto has authored or contributed to more than 30 publications. - She holds two U.S. patents and has presented at national and international conferences. - Her earlier honors include induction into the IAOTP Hall of Fame in 2024, IAOTP’s Lifetime Achievement Award in 2023 and Top Executive of the Decade in Research and Development of Pharmaceuticals in 2022. - Miotto has also been featured on the Reuters building in Times Square and on the Planet Hollywood billboard on the Las Vegas Strip. - Additional recognition includes IAOTP’s Presidential Award, multiple Marquis Who’s Who features, a Worldwide Who’s Who Lifetime Achievement honor, and distinctions as one of the 10 Most Influential Women Making a Difference in Healthcare in 2021 and the Most Influential Woman in Pharmaceutical Research and Development in 2019. - Metrendalytics was recently named one of the 10 Most Innovative Pharma and Biotech Solution Providers and one of the Top 30 Innovative Companies to Watch. - More information on the gala is available at the award gala page. - More information on Miotto is available at Metrendalytics. - IAOTP can also be found on LinkedIn, Instagram and YouTube.

Between the lines: - The award extends a long run of recognition for Miotto and reinforces her standing in pharmaceutical R&D. - The timing also suggests IAOTP is using its gala to elevate both individual leaders and the companies tied to them. - Metrendalytics’ focus on centralized, near-real-time data reflects a broader life-sciences push for faster and more efficient decision-making.

What’s next: - Miotto is set to receive the honor at IAOTP’s gala in New York City this December. - She plans to continue driving innovation, sharing her knowledge and helping businesses adopt modern strategies. - Metrendalytics is expected to keep advancing projects tied to pharmaceutical and life-sciences data and operations.

The bottom line: - IAOTP’s newest honor adds another credential to a career already built on pharmaceutical R&D, patents, publications and leadership.